Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Eloranta

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
BMJ Open|December 9, 2023
ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled studyKenny A Rodriguez-Wallberg, Hanna Pauline Nilsson, Jonas Bergh, et al.
European Journal of Haematology|July 22, 2024
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based studyRasmus Rask Kragh Jørgensen, Lasse Hjort Jakobsen, Sandra Eloranta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2019
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group StudyJorne Lionel Biccler, Ingrid Glimelius, Sandra Eloranta, et al.
British Journal of Haematology|December 29, 2023
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based studyJoachim Baech, Simon Husby, Trine Trab, et al.
Blood Advances|June 9, 2022
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapyJoachim Baech, Marianne Tang Severinsen, Andreas K Øvlisen, et al.
Blood Cancer Journal|January 28, 2022
Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in DenmarkLasse Hjort Jakobsen, Andreas Kiesbye Øvlisen, Marianne Tang Severinsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2021
Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based StudyAndreas K Øvlisen, Lasse H Jakobsen, Sandra Eloranta, et al.
Acta Oncologica (Stockholm, Sweden)|July 11, 2024
The National Swedish Lymphoma Register - a systematic validation of data qualityKarin Ekström Smedby, Sandra Eloranta, Tove Wästerlid, et al.
JCO Clinical Cancer Informatics|April 12, 2024
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin LymphomaRasmus Rask Kragh Jørgensen, Fanny Bergström, Sandra Eloranta, et al.
British Journal of Haematology|July 6, 2016
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateauChristian W Eskelund, Arne Kolstad, Mats Jerkeman, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
BMJ Open|December 9, 2023
ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled studyKenny A Rodriguez-Wallberg, Hanna Pauline Nilsson, Jonas Bergh, et al.
European Journal of Haematology|July 22, 2024
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based studyRasmus Rask Kragh Jørgensen, Lasse Hjort Jakobsen, Sandra Eloranta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2019
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group StudyJorne Lionel Biccler, Ingrid Glimelius, Sandra Eloranta, et al.
British Journal of Haematology|December 29, 2023
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based studyJoachim Baech, Simon Husby, Trine Trab, et al.
Blood Advances|June 9, 2022
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapyJoachim Baech, Marianne Tang Severinsen, Andreas K Øvlisen, et al.
Blood Cancer Journal|January 28, 2022
Patients in complete remission after R-CHOP(-like) therapy for diffuse large B-cell lymphoma have limited excess use of health care services in DenmarkLasse Hjort Jakobsen, Andreas Kiesbye Øvlisen, Marianne Tang Severinsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2021
Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based StudyAndreas K Øvlisen, Lasse H Jakobsen, Sandra Eloranta, et al.
Acta Oncologica (Stockholm, Sweden)|July 11, 2024
The National Swedish Lymphoma Register - a systematic validation of data qualityKarin Ekström Smedby, Sandra Eloranta, Tove Wästerlid, et al.
JCO Clinical Cancer Informatics|April 12, 2024
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin LymphomaRasmus Rask Kragh Jørgensen, Fanny Bergström, Sandra Eloranta, et al.
British Journal of Haematology|July 6, 2016
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateauChristian W Eskelund, Arne Kolstad, Mats Jerkeman, et al.
Pageof 11